Generative Artificial Intelligence (Gen AI) and Large Language Models (LLMs) have been around for several years. Their widespread adoption has recently surged, causing a tidal wave of expectations. ChatGPT, for example, reached 100 million users within just three months. Gen AI in healthcare is also gaining momentum, offering transformative potential in patient care, diagnostics, and research.

It is estimated that by 2045, AI could support 50% of activities, with Gen AI playing a significant role. As the evolution of older “discriminative” AI, it is poised to revolutionize healthcare.

Gen AI: unlocking efficiency and innovation in healthcare

Gen AI in healthcare has the potential to transform the entire healthcare sector. But perhaps the first industry to benefit will be Life Sciences, especially drug research. In healthcare services, the shift towards Gen AI and LLMs is gradual but expected to pick up speed. The insurance sector has been an early adopter of Gen AI, enabling it to now reinvent and enhance its procedures.

Deploying these models requires careful attention to ethical and regulatory issues, including security, transparency, unbiased decision-making, and environmental impact. Systematic human oversight, especially in healthcare, is crucial.

The risk-based approach of the upcoming European AI Act is expected to be widely adopted soon, with particular scrutiny on Gen AI for its most sensitive applications.

Supercharge healthcare through Gen AI

Explore our white paper to learn about the specifics of Gen AI and LLMs in healthcare: the main use cases, investment opportunities, purposes, and conditions.

Download the whitepaper
Book download image revided Gen ai in healthcare